Back to all news

Machine Learning Models Predict Cancer Risk with Routine Health Data

EurekAlertResearch

Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.

Key Details

  • 1Study used health data—including blood tests, medical history, and lifestyle—from 463,620 UK Biobank participants followed for 18 years.
  • 2About 500 machine learning models were developed for 20 common cancers; 57,055 participants developed cancer.
  • 3Performance was highest for lung, oesophageal, and liver cancers, with AUROC of 0.83 for combined cancer outcome at 15 years.
  • 4Predictive value came mostly from routine blood tests and medical history, with genetic and metabolomic data adding little improvement.
  • 5Models were tested and performed well across populations in the UK, US, and Japan, though predictive performance varied by cancer type.
  • 6A software toolbox (PRE-Screen) enabled large language models to apply the risk models, outperforming unaided LLMs.

Why It Matters

This approach could provide scalable, low-cost cancer pre-screening by leveraging existing clinical data, potentially influencing screening protocols and early detection. For radiology and imaging AI professionals, such tools may change referral patterns, resource allocation, and integration with imaging diagnostics in cancer pathways.

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.